PMDA held the GCP inspection in Multi-Regional Clinical Trial (MRCT) Webinar for the Food and Drug Administration, the Republic of the Philippines (FDA Philippines) on December 6, 2022.
This webinar was designed for regulators of pharmaceutical products in the FDA Philippines and counted 32 participants.
In the webinar, a PMDA staff from Office of Non-clinical and Clinical Compliance gave a lecture and case study on GCP Inspections. A Q&A session was also held to enhance understanding of the topic.
The PMDA continuously makes efforts to strengthen collaboration with the FDA Philippines through projects such as the PMDA-ATC for Pharmaceuticals and Medical Devices Regulatory Affairs.
See attached program
Back
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
International Activities
Safety Information
Advanced Efforts
-
Information for approved products in Japan
Safety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
-
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
Advanced efforts
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Reviews and Related Services
Regulatory Procedures
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety
Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC GCP inspection in MRCT Webinar 2022 for FDA Philippines
Events and Symposia